Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

LYELLYEL
5 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in LYELL IMMUNOPHARMA INC

NORTHERN TRUST CORP holds 118,500 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $1.7M as of 2026-Q2. The position was increased (+291.4% shares). LYEL represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$1.7M

Current Shares

118,500

Total Value Change

+$1.5M

Total Shares Change

+99,856

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
118,500
+291.4%
$1.7M0.0%$14.05
41
2026-Q1
Unchanged
30,280
0.0%
$607,4170.0%$23.33
0
2025-Q4
Increased
30,280
+7.7%
$932,0190.0%$31.59
27
2025-Q3
Increased
28,128
+50.9%
$456,7980.0%$14.97
33
2025-Q2
New
18,644
-
$164,8130.0%$8.94
34

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used